Catalyst OrthoScience Receives FDA 510(k) Clearance of its Reverse Shoulder System

Catalyst OrthoScience

Catalyst OrthoScience was granted FDA 510(k) clearance to market its reverse shoulder system. Limited U.S. launch will begin in 2Q21, followed by commercial launch later this year.

Catalyst’s reverse shoulder system is a single-tray arthroplasty system engineered to combine the most beneficial and evidence-based attributes of reverse...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us